Galectin Therapeutics Reports Significant Reduction in New Varices with Belapectin in U.S. Patient Population from the NAVIGATE Trial
Additional analysis of data from the NAVIGATE trial showed statistically significant 68.1% (p=0.02) reduction in the incidence of new varices ...
Galectin Therapeutics’ belapectin shows reduction in new varices
Galectin Therapeutics (GALT) announced additional results showing a statistically significant reduction in new varices in per-protocol patients ...
Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
Repurchasing all convertible note overhang, and - Funding pre-clinical and clinical trials - Management forfeiting $460,000 in accrued payroll. BOSTON, MASSACHUSETTS, Jan. 22, 2 ...
thorax.bmj27d
S76 Role of galectin-3 in the development of idiopathic pulmonary fibrosis
It has been shown that the ß-galactoside binding lectin galectin-3 can promote fibrosis through altering cellular responses to TGFß. 1 However, the precise mechanism of this is currently unknown.
BMJ15d
Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome
galectin-9 outperformed CXCL-10 or traditional markers of disease activity as an easy measurable biomarker to detect the IFN signature both in SLE and APS. Blood was drawn from patients with SLE, ...
asco.org7d
Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated biliary tract cancer.
Licensing available upon request. For more information, please contact [email protected] Galectin-9 as a regulator of immune interactions in the tumor microenvironment and novel therapeutic target in ...